![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 18, 15221-15224, May 3, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, February 25, 2002, and in revised form, March 11, 2002
Using sequence homology searches, yeast
two-hybrid assays and glutathione S-transferase
(GST)-pull-down approaches we have identified a series of glutamate
receptor subunits that interact differentially with the PDZ proteins
GRIP, PICK1, and syntenin. GST-pull-down experiments identified more
interactions than detected by yeast two-hybrid assays. We report
several receptor-protein interactions, strong ones include: (i) GRIP
and syntenin with mGluR7a, mGluR4a, and mGluR6; (ii) PICK1 and GRIP
with mGluR3; and (iii) syntenin with all forms of GluR1-4 and mGluR7b.
We further characterized the novel mGluR7a-GRIP interaction found both
in yeast two-hybrid and GST-pull-down assays and observed that mGluR7a localization overlapped with GRIP with in hippocampal neurons. The wide
range of targets for PICK1, GRIP, and syntenin suggests they may
represent a molecular mechanism that can concentrate and/or regulate a
number of different receptors at a common site on a synapse. These data
also suggest that the structural determinants involved in PDZ
interactions are more complex than originally envisaged.
Appropriate localization, cell surface expression, and
activity-dependant regulation of neurotransmitter receptors in neurons are essential for their function. These are achieved and maintained via
a complex network of protein-protein interactions, partly mediated by
PDZ (PSD-95/discs large/ZO-1) domain containing adaptor proteins (1).
PDZ domains comprise ~90 amino acids and bind proteins containing
extreme carboxyl-terminal
(ct)1-located PDZ binding
motifs with the consensus sequence E(S/T)X(V/I) (type
I), Glutamate is the main excitatory neurotransmitter in the vertebrate
central nervous system, and it regulates a number of cellular signaling
cascades and controls the excitability of central synapses pre-and
postsynaptically (5). To date, three major classes of
N-methyl-D-aspartate receptor subunits
(NR1-3), four Some PDZ domain-containing proteins expressed in neurons have been
shown to interact with glutamate receptor subtypes, where they act as
adaptor/scaffolding proteins that target, anchor, and spatially
organize synaptic proteins to the membrane (2). These interactions are
generally mediated by the cytoplasmic ct domains of the receptors. In
the present study we focused on PICK1 and GRIP, two proteins that have
been shown to dynamically regulate AMPAR cell surface expression (6).
We also included syntenin as an additional protein containing PDZ
domains (7).
Protein interacting with protein kinase C (PICK1) contains a single PDZ
domain that interacts with type I (PKC Glutamate receptor-interacting protein (GRIP) contains seven PDZ
domains with the potential to bind a diverse array of partners. Like
PICK1, GRIP (PDZ 4-5) interacts with GluR2-4 and GRIP (PDZ 6-7) with
ephrin ligands and receptors (12, 14, 15). It also binds to the type I
T/SXV motif of the huntingtin-associated protein HAP1-A
(16). Dimerization of GRIP had been shown to increase its scaffolding
abilities (17).
Syntenin was originally isolated as an interactor with syndecans (7).
It contains two closely located PDZ domains that share some (ephrinB1,
EphA7), but not all (EphB2), interacting proteins with PICK1 and GRIP.
The PDZ domains of syntenin can recognize type I (neurofascin,
ProTGF The present study was undertaken to investigate whether GRIP, PICK1,
and syntenin could bind to a variety of glutamate receptor subtypes.
Given the large number of AMPA, kainate, and
N-methyl-D-aspartate receptor subunits and the
multiple COOH-terminal splice variants, it was not feasible to
investigate all glutamate receptors. Therefore, as representative
examples, we studied one class of ionotropic receptors, namely the
AMPAR subunits GluR1-4 and all of the metabotropic receptors
mGluR1-8. Using yeast two-hybrid assays we identified a previously
unreported interaction between GRIP and mGluR7a, which was then further
characterized. Using GST-pull-down assays we also found more novel
receptor-PDZ protein interactions, suggesting general roles for PICK1,
GRIP, and syntenin in glutamate receptors regulation. Finally, taking
advantage of the number of PDZ binding motifs included in our study, we
analyzed the structural determinants involved in PDZ interactions.
Plasmid Construction and Yeast Two-hybrid Assays--
cDNA
fragments corresponding to the intracellular carboxyl-terminal domain
of the receptors (with the exception of mGluR1 and mGluR5, where only
the last 30 amino acids were fused) were amplified using PCR and
subcloned into the pBTM bait vector. The entire coding region of PICK1
and syntenin and PDZ 4-7 of GRIP were subcloned into the pGAD10 fish
vector (CLONTECH) as described previously (8). The
receptor COOH-terminal domain was fused to GST by subcloning into
pGEX-4T-1 (Amersham Biosciences), the Myc tag was added to the
NH2 terminus (nt) of GRIP PDZ domains 4-7 (residues
430-1112) by subcloning into pCMV-myc (CLONTECH), FLAG was tagged to the NH2 terminus of PICK1 as
described previously (8), and an HA tag was added to the
NH2 terminus of syntenin by subcloning into pCMV-HA
(CLONTECH). Small scale yeast transformations were
carried out as indicated elsewhere (19). Fish (pGAD10
constructs of PICK1, GRIP, and syntenin) and bait plasmids (pBTM
constructs of ct receptors) were cotransformed into Saccharomyces
cerevisiae L40 reporter strain and transformants were selected by
growth on synthetic dropout Trp/Leu plates. The colonies were
tested for activation of GST-pull-down Experiments--
For pull-down
experiments, extracts of Escherichia coli strain BL21 were
prepared using BugBuster (Novagen) in the presence of a Complete®
protease inhibitor mixture (Roche Molecular Biochemicals) and used as a
source of GST or GST fusion proteins. Lysates of COS-7 cells
transiently transfected with cDNA using FUGENE 6 (Roche Molecular
Biochemicals) were used as a source for FLAG-PICK1, Myc-GRIP(PDZ 4-7),
or HA-syntenin. GST-pull-downs were performed as described previously
(20). After GST-pull-down, the samples were processed for Western
blotting. Each interaction was verified by at least three independent
experiments. GST-ct-GluR2short was included as positive
control and used as reference interaction (i.e. 100%) in
the experiments. The intensity of bands on immunoblots was quantified
by densitometry using the Gel-Doc system (Bio-Rad).
Western Blotting and Immunocytochemistry--
Samples were
separated on 10% SDS-polyacrylamide gels (SDS-PAGE), and Western
blotting was performed. Primary antibodies (Abs) were as follows:
anti-Myc monoclonal mouse Ab (mAb) (Oncogen), anti-FLAG M2 mAb (Sigma),
and polyclonal rabbit anti-HA Ab (Santa Cruz Biotechnology). The
horseradish peroxidase-conjugated secondary antibodies used were goat
anti-rabbit IgG or goat anti-mouse IgG (Sigma). The signal was detected
using enhanced chemiluminescence (Roche Molecular Biochemicals). COS-7
cells were grown and transfected as described elsewhere (20). Low
density hippocampal cultures were prepared as described previously (20)
and used after 16-18 days in culture for immunocytochemistry. GRIP was
stained by anti-GRIP rabbit Ab (Upstate Biotechnology) followed by
Oregon green-conjugated donkey anti-rabbit IgG (Chemicon). mGluR7a was
stained by anti-mGluR7a guinea pig Ab (20) followed by Texas
Red-X-conjugated goat anti-guinea pig IgG (Molecular Probes). All
antibodies were used at dilutions recommended by the manufacturer.
Protein concentrations were determined using the BCA protein assay kit
using serum bovine albumin as a standard (Pierce).
Alignment of Glutamate Receptor Subunit ct
Motifs--
PDZ-mediated interactions have generally been reported to
occur via the recognition of a short motif that usually contains 3-7
critical residues located at the extreme ct domain (3). Therefore, we
examined closely the COOH terminus of GluR1-4 (AMPA) and
mGluR1-8 (metabotropic), of which some have already been shown to
interact with PDZ proteins (Fig. 1). In
the brain, the COOH termini of AMPARs are either long (GluR1 and
GluR2/4, also called GluR2c/4c) or short (GluR2/3/4) (21). Type II PDZ
binding motifs are found in the short versions of GluR2-4 (S(V/I)KI),
whereas GluR1 (TGL) contains a type I binding motif. The other extreme ct motifs of GluRs are nonconserved. For mGluRs, the last three residues of group I and II subtypes contain a common type I PDZ binding
motif (S(T/S)L). The sequences for group III subtypes are more
divergent, presenting either type II (mGluR7a/b) or type III (mGluR4a
and mGluR8a; H(A/S)I) PDZ binding motifs. A type IV
(XDXL) is also observed at the COOH terminus COOH
terminus of mGluR4b (Fig. 1). It is worth noting that mGluR7b
presents an atypical proline at position Yeast Two-hybrid Assays Revealed a New Interaction between GRIP and
mGluR7a--
We initially isolated full-length PICK1 and GRIP
comprising PDZ domains 4-7 in yeast two-hybrid screens using GluR2 or
GluR3 as a bait. Full-length syntenin was found in an independent
screen performed in our
laboratory.2 We then
performed a matrix of experiments to test the ability of a wide range
of AMPAR and mGluR ct domains to interact with the PDZ-domain
containing proteins PICK1 (entire coding region), GRIP (PDZ 4-7), and
syntenin (entire coding region). In the yeast two-hybrid assays
syntenin did not interact with either AMPARs or mGluRs. However our
results confirmed previously identified interactions (i.e.
GluR2-3short with GRIP or PICK1). In addition, GRIP (PDZ
4-7) and mGluR7a gave a strong
Next, we demonstrated that PDZ motif-domain association mediates the
mGluR7a-GRIP interaction. GluR2, mGluR7a, and mGluR7b shared the same
binding site for interaction with PICK1. However, whereas ct-GluR2
interacted with GRIP PDZ 4-5 (Fig. 2B, see Refs. 8 and 20),
ct-mGluR7a required the larger fragment GRIP PDZ 4-7. We found that
ct-mGluR7b, which has a proline at position
Similar to PICK1, the last 15 ct-located residues of mGluR7a were
sufficient for the interaction with GRIP (Fig. 2C, see Ref. 20). Point mutations within the PDZ motif of ct-mGluR7a all resulted in
a loss of interaction with GRIP and PICK1 (Fig. 2C). Exceptions occurred for NLVC, which had no effect on the
interaction with GRIP or PICK, and for NPVI that (similar
to mGluR7b, PPTV) showed interaction with PICK1 but not GRIP (Fig.
2C). A mutant based on ct-GluR2 (SVKI, wild type), namely
EVKI, has been shown to interact with PICK1 but not GRIP
(23, 24). Taken together, these results suggest that PDZ domains are
able to bind a larger number of motifs than currently predicted by the
classification of four types of PDZ ligands (types I, II, III, and IV).
We suggest that there are more PDZ binding motif types, which, together
with flexibility in PDZ domains, is likely to result in a number of PDZ
motif-domain interactions that is beyond complete predictability.
GST-pull-down Experiments Confirmed Yeast Two-hybrid Results and
Isolated Additional Novel Interactions--
To biochemically confirm
the mGluR7a-GRIP interaction found using yeast two-hybrid assays,
direct interaction between FLAG-PICK1, Myc-GRIP, or HA-syntenin and the
COOH termini of different glutamate receptors was assayed in
GST-pull-down experiments. In agreement with the results of the yeast
two-hybrid assay, GRIP was retained by GST-ct-mGluR7a (Fig.
3). Our densitometry results indicated that this interaction was comparable with that with
GluR2/3short. In our GST-pull-down assays we, as others
previously, observed an interaction between PICK1 and mGluR7a. Although
of weaker band intensity than that of GluR2short, this
PICK1-mGluR7a interaction is physiologically significant, being
involved in the presynaptic clustering of mGluR7a (22).
Surprisingly, we identified more glutamate receptor-PDZ protein
interactions in GST-pull-down experiments than in the yeast two-hybrid
assays. In particular, we observed a robust interaction between
syntenin and the COOH termini of GluR2/3short,
mGluR4a, and mGluR7a/b. We found that GRIP bound to mGluR4a with
intensity similar to its interaction with GluR2/3short.
However, neither GRIP nor syntenin bound the similar type III PDZ
binding motif of mGluR8a. An interaction, ranging between 25 and 75%
of intensity to GluR2short, was revealed between syntenin
and the long isoforms of AMPAR COOH terminus
(GluR1long, GluR2long, GluR4long)
or mGluR6. We also found binding between GRIP and mGluR7b or mGluR6.
Our GST-pull-down assays displayed virtually no interactions with group
I mGluRs (QSSSSL). In contrast, at the very least, interactions of
10-25% intensity to GluR2short were detected with mGluR3
(STTSSL). Despite the high sequence homology between the COOH
terminus of mGluR2 and mGluR3, the proteins, PICK, GRIP, and
syntenin displayed virtually no interaction with mGluR2. Taken
together, these data confirm the importance of the extreme COOH
terminus but also show the critical structural requirements of
amino acids located upstream of the PDZ binding motif.
We also observed weak intensity bands that indicated interactions not
previously reported. We found interactions between
ct-GluR1-4long and PICK1 or GRIP. Similar weak bands were
also seen for mGluR7a-PICK1, an interaction that has been shown to be
important for the receptor clustering (22). Whether, for
example, a GluR1-PICK1 interaction has any functional roles is unclear.
It has been shown that overexpression of PICK1 selectively alters the
surface expression of GluR2 but not that of GluR1 (26). One possibility
is that these interactions only become relevant in the absence of other
competitive interacting proteins and are only important at certain
developmental stages, cell states, or cell types. Assuming these
interactions are functionally relevant, it would appear that PICK1,
GRIP, and syntenin bind to a wider range of glutamate receptors than
previously proposed. Previously, PICK1 has been implicated in the
control of PKC-evoked receptor phosphorylation and receptor membrane
insertion and internalization (2, 6, 20). Syntenin may play a role in
the targeting, trafficking, or recycling of its interacting receptors
(27). GRIP anchors receptors at the synapse in a
phosphorylation-dependent manner (6, 23). Whether PICK1,
GRIP, and syntenin each have different roles depending on their
glutamate receptor partners remains to be resolved (6, 28).
GRIP Overlaps with mGluR7a at Excitatory Synapses--
We focused
on the further characterization of mGluR7a-GRIP interaction, because it
was robust in yeast two-hybrid and GST-pull-down studies. We examined
by immunofluorescence the cellular localization of both proteins in
cultured hippocampal neurons. As shown in Fig.
4, there was considerable overlap of GRIP
and mGluR7clusters on the dendritic shafts and cell bodies of
hippocampal pyramidal neurons. Previously, GRIP has been found
co-localized at excitatory glutamatergic synapses with GluR2 and at
inhibitory GABAergic terminals with glutamic acid decarboxylase (GAD)
(14, 17, 29). However, because mGluR7a (and PICK1) does not overlap
with GAD (22), we conclude that the staining found here is
localized at excitatory glutamatergic and not inhibitory GABAergic
neurons (Refs. 2, 13, and 20, but also see Ref. 21). Taken together, these results suggest that mGluR7a and GRIP (in addition to PICK1) are
spatially co-localized such that they could form complexes in
hippocampal neurons. The removal of the PDZ motif on mGluR7a alters its
surface expression, an event that has been associated with
mGluR7a-PICK1 interaction (22). Whether PICK1 and GRIP work in
combination to dynamically regulate mGluR7a cycling, as they do for
GluR2, remains to be established. The rapid turnover of not only
ionotropic but also metabotropic glutamate receptor numbers by PDZ
proteins could play an important molecular mechanism for regulating
synaptic strength and neuronal function.
In this present study we have used yeast two-hybrid assays to isolate a
novel PDZ-mediated interaction between mGluR7a and GRIP. Direct
interaction was confirmed by GST-pull-down assays that additionally
reveal a number of new interactions. Furthermore, we suggested that the
mGluR7a-GRIP interaction is likely to occur in vivo, because
both proteins appeared highly co-localized in hippocampal neurons. This
is relevant to the recent study, which shows that removal of the PDZ
binding motif from mGluR7a prevents its interaction with PICK1 at its
clustering at synapses (22). Our new results suggest that GRIP,
in addition to PICK1, may also play a role in these effects
(22). As a whole, our findings suggest that the current
classification for PDZ binding motifs and PDZ domains is incomplete and
that flanking amino acids residues and structural considerations can
play a crucial role in determining the specificity of PDZ motif-domain
interactions (4, 31).
We are grateful to Jo C. Francis,
Yoshiaki Nakajima, and Jun Kitano for supplying the constructs.
*
This work was supported in part by research grants from the
Medical Research Council (UK), the Wellcome Trust (UK), the France Alzheimer and AFRT (France), and the Ministry of Education, Science and
Culture of Japan (Japan).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Novartis
Pharma AG, Nervous System Research, CH-4002 Basel, Switzerland. Tel.: 41-61-324-29-42; Fax: 41-61-324-38-11; E-mail:
kumlesh_k.dev@pharma.novartis.com.
Published, JBC Papers in Press, March 12, 2002, DOI 10.1074/jbc.C200112200
2
H. Hirbec and J. M. Henley, unpublished observations.
The abbreviations used are:
ct, carboxyl
(or COOH)-terminal;
AMPA,
ACCELERATED PUBLICATION
The PDZ Proteins PICK1, GRIP, and Syntenin Bind Multiple
Glutamate Receptor Subtypes
ANALYSIS OF PDZ BINDING MOTIFS*
,
,
,
,
, and
§¶
Department of Anatomy, Medical Research
Council Centre of Synaptic Plasticity, Medical School, University of
Bristol, Bristol BS8 1TD, United Kingdom and the
§ Department of Biological Sciences, Kyoto University,
Faculty of Medicine, Kyoto 606-8501, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
X
(type II), and/or
/
X
(type III) (2, 3), where
× is any amino acid,
is a hydrophobic residue,
is a basic residue. A fourth class (type IV) has also being defined by
Stricker and co-workers and corresponds to the
XDXV ct sequence (4).
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
receptor (AMPAR) subunits (GluR1-4), five kainate receptor subunits
(GluR5-7, KA1-2), and eight metabotropic receptors (mGluR1-8) have
been reported (5).
), type II (GluR2-4, ephrin
ligands and receptors, ADP-ribosylation factor, dopamine transporter
and mGluR7a) as well as atypical PDZ binding motifs (TIS21) (2, 8-13).
In the yeast two-hydrid assay, PICK1 has also been shown to interact
weakly with the type III PDZ binding motifs of mGluR4a and mGluR8a (2).
In addition, PICK1 is a substrate for PKC phosphorylation and forms
dimers at a site distinct from the PDZ domain, possibly at the
coiled-coil motif (10, 11). It has therefore been proposed that PICK1
might serve as an adaptor that links transmembrane receptors to
cytoplasmic PKC.
), type II (syndecans, ephrin-B2, EphA7, and r-PTP
) and
nonconserved PDZ binding motifs (Schwannomin-FEEL) (20-24). Syntenin
can also dimerize, through a site that is currently unknown (18).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-galactosidase reporter gene by filter assays.
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
2 and that mGluR6 and
mGluR8b are nonconserved. Since variations among these receptors occur at the extreme COOH terminus, within the PDZ binding motifs, we expected that proteins interacting with this region might be different. Fig. 1 shows the summary of AMPAR and mGluR carboxyl-terminal sequences
(containing the ct motifs) and their previously reported PDZ
domain-interacting proteins. It also gives the overview of newly
identified receptor-PDZ protein interactions.

View larger version (38K):
[in a new window]
Fig. 1.
Alignment of AMPAR and mGluR COOH
termini. Proteins previously shown to interact with glutamate
receptors are indicated. Novel receptor-protein interactions isolated
in this study by yeast two-hybrid studies and/or GST-pull-down
experiments are also listed.
-galactosidase signal in the yeast
two-hybrid assay (Fig. 2A, see
boldface material). This mGluR7a-GRIP interaction is
interesting in light of reports that have already shown an interaction
between PICK1 and mGluR7a (22), and it is also analogous to the
interaction of both PICK1 and GRIP with GluR2 (8, 13, 14).

View larger version (16K):
[in a new window]
Fig. 2.
Characterization of the novel GRIP-mGluR7a
interaction. Positive interactions, as defined by filter
-galactosidase assays, are indicated as + and negative as
. A, a novel interaction between mGluR7a and
GRIP is isolated and is indicated as + in bold.
B, GluR2, mGluR7a, and mGluR7b use the PDZ domain of PICK1
for interaction. GluR2 can interact with PDZ 4-5 of GRIP, mGluR7a
requires PDZ 4-7, and mGluR7b does not show any affinity for GRIP PDZ
4-7. C, both PICK1 and GRIP use the extreme 15 residues of
ct-mGluR7a for interaction. Random mutations in the last three residues
of ct-mGluR7a show the binding profiles of PICK1 and GRIP PDZ
domains.
2, did not bind GRIP
(Fig. 2B). Generally one PDZ motif binds to one PDZ domain.
However, GRIP requires multiple PDZ domains to work in combination, for
example GluR2-GRIP (PDZ 4-5) (14) and Eph-GRIP (PDZ 6-7) (12). This
suggests that the single PDZ domain in PICK1 is likely to have a
broader binding capacity than single PDZ domain of GRIP and that PDZ
domains in GRIP may act in concert possibly via conformation changes in
the protein.

View larger version (57K):
[in a new window]
Fig. 3.
GST-pull-down experiments.
Experiments confirm the interaction between mGluR7a-GRIP. A,
examples of Western blots using anti-FLAG, anti-Myc, and anti-HA Abs
and indicating the levels of FLAG-PICK1, Myc-GRIP, and HA-syntenin
retained, respectively. B, summary of GST-pull-down assays.
The intensity of bands on immunoblots was compared by densitometry
using the Gel-Doc system (Bio-Rad). Values are expressed as percent of
FLAG-PICK1, Myc-GRIP (PDZ 4-7), or HA-syntenin retained by
ct-GluR2short. Ranking of the strength of the interactions
found is as followed, in percent retained by ct-GluR2short:
, no interaction; (+), <10%; +,
10-25%; ++, 25-75%; +++, >75%.

View larger version (43K):
[in a new window]
Fig. 4.
GRIP and mGluR7a distribution in rat
hippocampal neurons. Hippocampal neurons were immunostained
for GRIP and mGluR7a proteins. GRIP was stained by anti-GRIP rabbit Ab
followed by Oregon green-conjugated rabbit IgG, green
channel. mGluR7a was stained by anti-mGluR7a guinea pig Ab
followed by Texas Red-X-conjugated anti-guinea pig IgG, red
channel. Overlay shows considerable overlap in GRIP and mGluR7a
staining along neuron process and on cell bodies, yellow
channel.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid;
AMPAR, AMPA
receptor;
PKC, protein kinase C;
GRIP, glutamate receptor-interacting
protein;
GST, glutathione S-transferase;
Ab, antibody;
mAb, monoclonal antibody;
GAD, glutamic acid decarboxylase.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
1.
Ponting, C. P.,
Phillips, C.,
Davies, K. E.,
and Blake, D. J.
(1997)
Bioessays
19,
469-479[CrossRef][Medline]
[Order article via Infotrieve] 2.
Dev, K. K.,
Nakanishi, S.,
and Henley, J. M.
(2001)
Trends Pharmacol. Sci.
22,
355-361[CrossRef][Medline]
[Order article via Infotrieve] 3.
Songyang, Z.,
Fanning, A. S., Fu, C., Xu, J.,
Marfatia, S. M.,
Chishti, A. H.,
Crompton, A.,
Chan, A. C.,
Anderson, J. M.,
and Cantley, L. C.
(1997)
Science
275,
73-77 4.
Sheng, M.,
and Sala, C.
(2001)
Annu. Rev. Neurosci.
24,
1-29[CrossRef][Medline]
[Order article via Infotrieve] 5.
Hollmann, M.,
and Heinemann, S.
(1994)
Annu. Rev. Neurosci.
17,
31-108[CrossRef][Medline]
[Order article via Infotrieve] 6.
Daw, M. I.,
Chittajallu, R.,
Bortolotto, Z. A.,
Dev, K. K.,
Duprat, F.,
Henley, J. M.,
Collingridge, G. L.,
and Isaac, J. T.
(2000)
Neuron
28,
873-886[CrossRef][Medline]
[Order article via Infotrieve] 7.
Grootjans, J. J.,
Zimmermann, P.,
Reekmans, G.,
Smets, A.,
Degeest, G.,
Durr, J.,
and David, G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13683-13688 8.
Dev, K. K.,
Nishimune, A.,
Henley, J. M.,
and Nakanishi, S.
(1999)
Neuropharmacology
38,
635-644[CrossRef][Medline]
[Order article via Infotrieve] 9.
Lin, W. J.,
Chang, Y. F.,
Wang, W. L.,
and Huang, C. Y.
(2001)
Biochem. J.
354,
635-643[CrossRef][Medline]
[Order article via Infotrieve] 10.
Staudinger, J.,
Zhou, J.,
Burgess, R.,
Elledge, S. J.,
and Olson, E. N.
(1995)
J. Cell Biol.
128,
263-271 11.
Staudinger, J., Lu, J.,
and Olson, E. N.
(1997)
J. Biol. Chem.
272,
32019-32024 12.
Torres, G. E.,
Yao, W. D.,
Mohn, A. R.,
Quan, H.,
Kim, K. M.,
Levey, A. I.,
Staudinger, J.,
and Caron, M. G.
(2001)
Neuron
30,
121-134[CrossRef][Medline]
[Order article via Infotrieve] 13.
Xia, J.,
Zhang, X.,
Staudinger, J.,
and Huganir, R. L.
(1999)
Neuron
22,
179-187[CrossRef][Medline]
[Order article via Infotrieve] 14.
Dong, H.,
O'Brien, R. J.,
Fung, E. T.,
Lanahan, A. A.,
Worley, P. F.,
and Huganir, R. L.
(1997)
Nature
386,
279-284[CrossRef][Medline]
[Order article via Infotrieve] 15.
Hsueh, Y. P.,
and Sheng, M.
(1998)
Neuron
21,
1227-1229[Medline]
[Order article via Infotrieve] 16.
Ye, B.,
Liao, D.,
Zhang, X.,
Zhang, P.,
Dong, H.,
and Huganir, R. L.
(2000)
Neuron
26,
603-617[CrossRef][Medline]
[Order article via Infotrieve] 17.
Dong, H.,
Zhang, P.,
Song, I.,
Petralia, R. S.,
Liao, D.,
and Huganir, R. L.
(1999)
J. Neurosci.
19,
6930-6941 18.
Koroll, M.,
Rathjen, F. G.,
and Volkmer, H.
(2001)
J. Biol. Chem.
276,
10646-10654 19.
Vojtek, A. B.,
Hollenberg, S. M.,
and Cooper, J. A.
(1993)
Cell
74,
205-214[CrossRef][Medline]
[Order article via Infotrieve] 20.
Dev, K. K.,
Nakajima, Y.,
Kitano, J.,
Braithwaite, S. P.,
Henley, J. M.,
and Nakanishi, S.
(2000)
J. Neurosci.
20,
7252-7257 21.
Kohler, M.,
Kornau, H. C.,
and Seeburg, P. H.
(1994)
J. Biol. Chem.
269,
17367-17370 22.
Boudin, H.,
Doan, A.,
Xia, J.,
Shigemoto, R.,
Huganir, R. L.,
Worley, P.,
and Craig, A. M.
(2000)
Neuron
28,
485-497[CrossRef][Medline]
[Order article via Infotrieve] 23.
Chung, H. J.,
Xia, J.,
Scannevin, R. H.,
Zhang, X.,
and Huganir, R. L.
(2000)
J. Neurosci.
20,
7258-7267 24.
Matsuda, S.,
Launey, T.,
Mikawa, S.,
and Hirai, H.
(2000)
EMBO J.
19,
2765-2774[CrossRef][Medline]
[Order article via Infotrieve] 25.
Bezprozvanny, I.,
and Maximov, A.
(2001)
FEBS Lett.
509,
457-462[CrossRef][Medline]
[Order article via Infotrieve] 26.
Perez, J. L.,
Khatri, L.,
Chang, C.,
Srivastava, S.,
Osten, P.,
and Ziff, E. B.
(2001)
J. Neurosci.
21,
5417-5428 27.
Fernandez-Larrea, J.,
Merlos-Suarez, A.,
Urena, J. M.,
Baselga, J.,
and Arribas, J.
(1999)
Mol Cell
3,
423-433[CrossRef][Medline]
[Order article via Infotrieve] 28.
Osten, P.,
Khatri, L.,
Perez, J. L.,
Kohr, G.,
Giese, G.,
Daly, C.,
Schulz, T. W.,
Wensky, A.,
Lee, L. M.,
and Ziff, E. B.
(2000)
Neuron
27,
313-325[CrossRef][Medline]
[Order article via Infotrieve] 29.
Wyszynski, M.,
Valtschanoff, J. G.,
Naisbitt, S.,
Dunah, A. W.,
Kim, E.,
Standaert, D. G.,
Weinberg, R.,
and Sheng, M.
(1999)
J. Neurosci.
19,
6528-6537
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
D. Sarkar, H. Boukerche, Z.-z. Su, and P. B. Fisher mda-9/Syntenin: More than Just a Simple Adapter Protein When It Comes to Cancer Metastasis Cancer Res., May 1, 2008; 68(9): 3087 - 3093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Beekman and P. J. Coffer The ins and outs of syntenin, a multifunctional intracellular adaptor protein J. Cell Sci., May 1, 2008; 121(9): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chatterjee, J. Stegmuller, P. Schatzle, K. Karram, M. Koroll, H. B. Werner, K.-A. Nave, and J. Trotter Interaction of Syntenin-1 and the NG2 Proteoglycan in Migratory Oligodendrocyte Precursor Cells J. Biol. Chem., March 28, 2008; 283(13): 8310 - 8317. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Latysheva, G. Muratov, S. Rajesh, M. Padgett, N. A. Hotchin, M. Overduin, and F. Berditchevski Syntenin-1 Is a New Component of Tetraspanin-Enriched Microdomains: Mechanisms and Consequences of the Interaction of Syntenin-1 with CD63 Mol. Cell. Biol., October 15, 2006; 26(20): 7707 - 7718. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Baxter and D. J. A. Wyllie Phosphatidylinositol 3 kinase activation and AMPA receptor subunit trafficking underlie the potentiation of miniature EPSC amplitudes triggered by the activation of L-type calcium channels. J. Neurosci., May 17, 2006; 26(20): 5456 - 5469. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Gindhart Towards an understanding of kinesin-1 dependent transport pathways through the study of protein-protein interactions Brief Funct Genomic Proteomic, March 1, 2006; 5(1): 74 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cui, K. J. Dougherty, D. W. Machacek, M. Sawchuk, S. Hochman, and D. J. Baro Divergence between motoneurons: gene expression profiling provides a molecular characterization of functionally discrete somatic and autonomic motoneurons Physiol Genomics, February 23, 2006; 24(3): 276 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ko, C. Yoon, G. Piccoli, H. S. Chung, K. Kim, J.-R. Lee, H. W. Lee, H. Kim, C. Sala, and E. Kim Organization of the Presynaptic Active Zone by ERC2/CAST1-Dependent Clustering of the Tandem PDZ Protein Syntenin-1 J. Neurosci., January 18, 2006; 26(3): 963 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Irino, M. Ichinohe, Y. Nakamura, M. Nakahara, and K. Fukami Phospholipase C{delta}4 Associates with Glutamate Receptor Interacting Protein 1 in Testis J. Biochem., October 1, 2005; 138(4): 451 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gimferrer, A. Ibanez, M. Farnos, M.-R. Sarrias, R. Fenutria, S. Rosello, P. Zimmermann, G. David, J. Vives, C. Serra-Pages, et al. The Lymphocyte Receptor CD6 Interacts with Syntenin-1, a Scaffolding Protein Containing PDZ Domains J. Immunol., August 1, 2005; 175(3): 1406 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Palmer, L. Cotton, and J. M. Henley The Molecular Pharmacology and Cell Biology of {alpha}-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Pharmacol. Rev., June 1, 2005; 57(2): 253 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Madsen, T. Beuming, M. Y. Niv, C.-w. Chang, K. K. Dev, H. Weinstein, and U. Gether Molecular Determinants for the Complex Binding Specificity of the PDZ Domain in PICK1 J. Biol. Chem., May 27, 2005; 280(21): 20539 - 20548. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Li, H.-Y. Li, B.-F. Jin, Q.-N. Ye, T. Zhou, X.-D. Yu, X. Pan, J.-H. Man, K. He, M. Yu, et al. A Novel eIF5A Complex Functions As a Regulator of p53 and p53-dependent Apoptosis J. Biol. Chem., November 19, 2004; 279(47): 49251 - 49258. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. D. A. Excoffon, A. Hruska-Hageman, M. Klotz, G. L. Traver, and J. Zabner A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth J. Cell Sci., September 1, 2004; 117(19): 4401 - 4409. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bjerggaard, J. U. Fog, H. Hastrup, K. Madsen, C. J. Loland, J. A. Javitch, and U. Gether Surface Targeting of the Dopamine Transporter Involves Discrete Epitopes in the Distal C Terminus But Does Not Require Canonical PDZ Domain Interactions J. Neurosci., August 4, 2004; 24(31): 7024 - 7036. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. McFEETERS and R. E. OSWALD Emerging structural explanations of ionotropic glutamate receptor function FASEB J, March 1, 2004; 18(3): 428 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Flajolet, S. Rakhilin, H. Wang, N. Starkova, N. Nuangchamnong, A. C. Nairn, and P. Greengard Protein phosphatase 2C binds selectively to and dephosphorylates metabotropic glutamate receptor 3 PNAS, December 23, 2003; 100(26): 16006 - 16011. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Croci, H. Sticht, J. H. Brandstatter, and R. Enz Group I Metabotropic Glutamate Receptors Bind to Protein Phosphatase 1C: MAPPING AND MODELING OF INTERACTING SEQUENCES J. Biol. Chem., December 12, 2003; 278(50): 50682 - 50690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Williams, S. C.-Y. Wu, W. L. McKenna, and L. Hinck Surface Expression of the Netrin Receptor UNC5H1 Is Regulated through a Protein Kinase C-Interacting Protein/Protein Kinase-Dependent Mechanism J. Neurosci., December 10, 2003; 23(36): 11279 - 11288. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bannert, K. Vollhardt, B. Asomuddinov, M. Haag, H. Konig, S. Norley, and R. Kurth PDZ Domain-mediated Interaction of Interleukin-16 Precursor Proteins with Myosin Phosphatase Targeting Subunits J. Biol. Chem., October 24, 2003; 278(43): 42190 - 42199. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hassel, M. Schreff, E.-M. Stube, U. Blaich, and S. Schumacher CALEB/NGC Interacts with the Golgi-associated Protein PIST J. Biol. Chem., October 10, 2003; 278(41): 40136 - 40143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Correia, C. B. Duarte, C. J. Faro, E. V. Pires, and A. L. Carvalho Protein Kinase Cgamma Associates Directly with the GluR4 alpha -Amino-3-hydroxy-5-methyl-4-isoxazole Propionate Receptor Subunit. EFFECT ON RECEPTOR PHOSPHORYLATION J. Biol. Chem., February 14, 2003; 278(8): 6307 - 6313. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Baron, E. Deval, M. Salinas, E. Lingueglia, N. Voilley, and M. Lazdunski Protein Kinase C Stimulates the Acid-sensing Ion Channel ASIC2a via the PDZ Domain-containing Protein PICK1 J. Biol. Chem., December 20, 2002; 277(52): 50463 - 50468. [Abstract] [Full Text] [PDF] |
||||
| |||||||||